Therapeutic Glypican‐3 CRISPR Genome‐Editing Using UltraLarge Porous Silica Nano‐Depot for the Treatment of Hepatocellular Carcinoma

S Lee, S Lee, H Lee, S Kim, DH Kim - Small Science, 2024 - Wiley Online Library
Glypican‐3 (GPC3) is a key diagnostic marker and therapeutic target in hepatocellular
carcinoma (HCC), interacting with Wnt and Hippo/YAP pathways related to cancer …